IAMBIC THERAPEUTICS

EUIPO EUIPO 2023 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark IAMBIC THERAPEUTICS was filed as Word mark on 08/09/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 01/06/2024. The current status of the mark is "Trademark registered".

Trademark Details Last update: June 10, 2024

Trademark form Word mark
File reference 018911911
Application date August 9, 2023
Publication date September 25, 2023
Entry date January 6, 2024
Expiration date August 9, 2033

Trademark owner

5627 Oberlin Drive, Suite 120
92121 San Diego
US

Trademark representatives

Leopoldstr. 4 80802 München DE

goods and services

1 chemical and biological agents for scientific and research use
5 pharmaceuticals; pharmaceutical preparations for treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders; chemical preparations and biological preparations for the treatment of diseases and disorders; veterinary preparations
9 software; software applications; downloadable software for optimizing the development and discovering of new and existing molecules, drugs, and batteries, all for use in the field of computer science, chemistry, biochemistry, physics, chemical engineering, and biology; downloadable software applications for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products; customized downloadable computer software using artificial intelligence and machine learning to provide bespoke digital simulations in the fields of chemistry, physics, biology, biochemistry, computer science, and chemical engineering
42 research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consulting; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software; software as a service (SaaS); platform as a Service (PaaS); cloud computing; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (saas) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (paas) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products

Trademark history

Date Document number Area Entry
April 4, 2024 Transfer / Change of address, Published
September 21, 2023 Transfer / Change of address, Registered

ID: 11018911911